ChartRow logo
ChartRow
Investing Charts
LLY
Eli Lilly and CompanyStock · HealthcareS&P 500 1.3%
$1,196.04+$10.17 (+0.86%)as of market close, Jul 24, 2026
CompareUNHJNJABBVISRGABTMRK

LLYEli Lilly and Company stock price, chart and key statistics

Key stats

Price data

Price
$1,196.04
Change YTD
+10.71%
Next earnings
Aug 5, 2026 · Before open
Market cap
1.1T
Enterprise value
1.2T
Shares outstanding
941.7M
52W low
$623.78
52W high
$1,249.45
From 52W high
-4.27%
From 52W low
+91.74%
52W range
91%
Beta
0.51

Volume

Rel volume
1.02×
30D volume
2.8M
30D $ vol
3.2B

Fundamentals

Sales (ttm)
72.2B
Sales/share
$76.72
EPS (ttm)
$28.21
FCF (ttm)
16.8B
FCF/share
$17.85
Book value/share
$33.13
Net margin
34.99%
ROE
81.02%
ROA
21.68%
Debt / equity
1.26×
Current ratio
1.50

Growth (CAGR, ttm) · 10Y

Sales
+13.61%
Net income
+26.99%
Shares
-1.58%

Per-share growth (CAGR, ttm) · 10Y

EPS
+29.25%
Sales/share
+15.42%
Book value/share
+9.31%
Dividend/share
+12.03%
Price
+30.79%
Total return
+32.90%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
44.6×
Fwd P/E
26.4×
P/S (ttm)
15.6×
P/B (mrq)
36.1×
P/FCF (ttm)
67.0×
EV/Sales (ttm)
16.1×
FCF yield (ttm)
1.49%
Dividend yield (fwd)
0.58%
Dividend/share (fwd)
$6.92
Buyback yield (ttm)
0.47%
Shareholder yield (ttm)
0.96%

Vs own 10Y history

P/E
53rd
P/S
81st
P/B
60th

Bar = where today's multiple sits in LLY's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.86%
1W
+1.44%
1M
+7.05%
3M
+30.34%
YTD
+10.71%
1Y
+49.71%
5Y
+414.51%

Financial statements

Open full LLY financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B
GILD
Gilead Sciences Inc.
Biotech$129+3.32%976.5M

Eli Lilly and Company (LLY) trades at $1,196.04 with a live price and an interactive chart covering 54+ years of daily price history, plus key valuation metrics. ChartRow also publishes LLY's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full LLY financial statements →